Search for tag: "phs580"

107 Media

08:21 Lecture 6.2. Assessment and Reporting of Harm… Lecture 6.2. Assessment and Reporting of Harm (Part 5) [PHS580]	Lecture 6.2. Assessment and Reporting of Harm (Part 5) [PHS580] phs580 l06 From Chulapol Thanomsing 0 likes 5 plays 0 Usage Course Material
07:28 Lecture 6.2. Assessment and Reporting of Harm… Lecture 6.2. Assessment and Reporting of Harm (Part 4) [PHS580]	Lecture 6.2. Assessment and Reporting of Harm (Part 4) [PHS580] phs580 l06 From Chulapol Thanomsing 0 likes 4 plays 0 Usage Course Material
05:37 Lecture 6.2. Assessment and Reporting of Harm… Lecture 6.2. Assessment and Reporting of Harm (Part 3) [PHS580]	Lecture 6.2. Assessment and Reporting of Harm (Part 3) [PHS580] phs580 l06 From Chulapol Thanomsing 0 likes 4 plays 0 Usage Course Material
06:19 Lecture 6.2. Assessment and Reporting of Harm… Lecture 6.2. Assessment and Reporting of Harm (Part 2) [PHS580]	Lecture 6.2. Assessment and Reporting of Harm (Part 2) [PHS580] phs580 l06 From Chulapol Thanomsing 0 likes 5 plays 0 Usage Course Material
04:28 Lecture 6.2. Assessment and Reporting of Harm… Lecture 6.2. Assessment and Reporting of Harm (Part 1) [PHS580]	Lecture 6.2. Assessment and Reporting of Harm (Part 1) [PHS580] phs580 l06 From Chulapol Thanomsing 0 likes 6 plays 0 Usage Course Material
09:11 Lecture 12.1. Meta-Analysis (Part 7) [PHS580] Lecture 12.1. Meta-Analysis (Part 7) [PHS580]	Lecture 12.1. Meta-Analysis (Part 7) [PHS580] phs580 l13 From Chulapol Thanomsing 0 likes 2 plays 0 Usage Course Material
12:47 Lecture 12.1. Meta-Analysis (Part 4) [PHS580] Lecture 12.1. Meta-Analysis (Part 4) [PHS580]	Lecture 12.1. Meta-Analysis (Part 4) [PHS580] phs580 l13 From Chulapol Thanomsing 0 likes 3 plays 0 Usage Course Material
13:33 Lecture 12.1. Meta-Analysis (Part 6) [PHS580] Lecture 12.1. Meta-Analysis (Part 6) [PHS580]	Lecture 12.1. Meta-Analysis (Part 6) [PHS580] phs580 l13 From Chulapol Thanomsing 0 likes 3 plays 0 Usage Course Material
14:43 Lecture 12.1. Meta-Analysis (Part 3) [PHS580] Lecture 12.1. Meta-Analysis (Part 3) [PHS580]	Lecture 12.1. Meta-Analysis (Part 3) [PHS580] phs580 l13 From Chulapol Thanomsing 0 likes 4 plays 0 Usage Course Material
09:12 Lecture 12.1. Meta-Analysis (Part 5) [PHS580] Lecture 12.1. Meta-Analysis (Part 5) [PHS580]	Lecture 12.1. Meta-Analysis (Part 5) [PHS580] phs580 l13 From Chulapol Thanomsing 0 likes 2 plays 0 Usage Course Material
19:43 Lecture 12.1. Meta-Analysis (Part 2) [PHS580] Lecture 12.1. Meta-Analysis (Part 2) [PHS580]	Lecture 12.1. Meta-Analysis (Part 2) [PHS580] phs580 l13 From Chulapol Thanomsing 0 likes 3 plays 0 Usage Course Material
07:30 Lecture 12.1. Meta-Analysis (Part 1) [PHS580] Lecture 12.1. Meta-Analysis (Part 1) [PHS580]	Lecture 12.1. Meta-Analysis (Part 1) [PHS580] phs580 l13 From Chulapol Thanomsing 0 likes 4 plays 0 Usage Course Material
17:14 Lecture 13.1. Early Phase Trial Design (Part 4)… Lecture 13.1. Early Phase Trial Design (Part 4) [PHS580]	Lecture 13.1. Early Phase Trial Design (Part 4) [PHS580] phs580 l12 From Chulapol Thanomsing 0 likes 3 plays 0 Usage Course Material
12:31 Lecture 13.1. Early Phase Trial Design (Part 3)… Lecture 13.1. Early Phase Trial Design (Part 3) [PHS580]	Lecture 13.1. Early Phase Trial Design (Part 3) [PHS580] phs580 l12 From Chulapol Thanomsing 1 likes 6 plays 0 Usage Course Material
16:05 Lecture 13.1. Early Phase Trial Design (Part 2)… Lecture 13.1. Early Phase Trial Design (Part 2) [PHS580]	Lecture 13.1. Early Phase Trial Design (Part 2) [PHS580] phs580 l12 From Chulapol Thanomsing 0 likes 5 plays 0 Usage Course Material
09:56 Lecture 13.1. Early Phase Trial Design (Part 1)… Lecture 13.1. Early Phase Trial Design (Part 1) [PHS580]	Lecture 13.1. Early Phase Trial Design (Part 1) [PHS580] phs580 l12 From Chulapol Thanomsing 0 likes 5 plays 0 Usage Course Material

This publication is available in alternative media on request. Penn State is an equal opportunity, affirmative action employer, and is committed to providing employment opportunities to all qualified applicants without regard to race, color, religion, age, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.